CAS 128517-07-7
:(1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dit hia-3,6,18,21-tetrazabicyclo[8.7.6]tricos-11-ene-2,5,8,19,22-pentone
Description:
The chemical substance with the name "(1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dithia-3,6,18,21-tetrazabicyclo[8.7.6]tricos-11-ene-2,5,8,19,22-pentone" and CAS number "128517-07-7" is a complex organic compound characterized by its unique bicyclic structure, which incorporates multiple functional groups including oxo and thia moieties. The stereochemistry indicated by the (S) and (Z) designations suggests specific spatial arrangements of atoms, which can significantly influence the compound's reactivity and interactions. The presence of multiple alkyl groups, such as ethylidene and dipropan-2-yl, contributes to its hydrophobic characteristics, while the bicyclic framework may impart rigidity to the molecule. This compound is likely to exhibit interesting chemical properties, including potential biological activity, due to its intricate structure. Its applications could span various fields, including pharmaceuticals and materials science, although specific uses would depend on further research into its properties and behavior in different environments.
Formula:C24H36N4O6S2
InChI:InChI=1/C24H36N4O6S2/c1-6-16-21(30)28-20(14(4)5)24(33)34-15-9-7-8-10-35-36-12-17(22(31)25-16)26-23(32)19(13(2)3)27-18(29)11-15/h6-7,9,13-15,17,19-20H,8,10-12H2,1-5H3,(H,25,31)(H,26,32)(H,27,29)(H,28,30)/b9-7+,16-6-/t15-,17+,19+,20-/m0/s1
Synonyms:- Fr 901228
- Romidepsin
- (1R,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-bis(1-methylethyl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 9 products.
Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl], cyclic (3→5)-disulfide
CAS:Formula:C24H36N4O6S2Purity:98%Color and Shape:SolidMolecular weight:540.6958Ref: IN-DA000Y5C
1gTo inquire1mg174.00€5mg194.00€10mg289.00€50mg502.00€100mgTo inquire250mgTo inquire500mgTo inquireRomidepsin
CAS:<p>Romidepsin (NSC-630176), an IV histone deacetylase inhibitor, treats refractory cutaneous/peripheral T-cell lymphomas.</p>Formula:C24H36N4O6S2Purity:99.4% - 99.94%Color and Shape:SolidMolecular weight:540.7Romidepsin
CAS:Controlled Product<p>Applications Romidepsin is a histone deacetylase inhibitor that can alter chromatin structure and gene transcription leading to multiple changes in cellular protein production. This may result in cell cycle arrest and tumor growth inhibition. Romidepsin has shown anti-proliferative activity in vitro against multiple mouse and human tumor cell lines and in vivo in human tumor xenograft models. Romidepsin can be administered with a second agent, such as a cytotoxic agent, a steroidal agent, a proteasome inhibitor, or a kinase inhibitor.<br>References Ueda, H., et al.: J. Antibiot., 47, 301 (1994), Weidle, U., et al.: Anticancer Res., 20, 1471 (2000), Kitazono, M., et al.: Cancer Res., 61, 6328 (2001), Sandor, V., et al.: Clin. Cancer Res., 8, 718 (2002),<br></p>Formula:C24H36N4O6S2Color and Shape:White To Off-WhiteMolecular weight:540.70Romidepsin
CAS:<p>Natural anti-cancer agent; inhibitor of histone deacetylases</p>Formula:C24H36N4O6S2Purity:Min. 95 Area-%Color and Shape:White PowderMolecular weight:540.7 g/molRomidepsin - Bio-X ™
CAS:<p>This product is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.</p>Formula:C24H36N4O6S2Purity:Min. 95%Color and Shape:PowderMolecular weight:540.7 g/molRomidepsin-d8
CAS:Controlled Product<p>Applications Labelled Romidepsin (R425060). Romidepsin is a histone deacetylase inhibitor that can alter chromatin structure and gene transcription leading to multiple changes in cellular protein production. This may result in cell cycle arrest and tumor growth inhibition. Romidepsin has shown anti-proliferative activity in vitro against multiple mouse and human tumor cell lines and in vivo in human tumor xenograft models. Romidepsin can be administered with a second agent, such as a cytotoxic agent, a steroidal agent, a proteasome inhibitor, or a kinase inhibitor.<br>References Ueda, H., et al.: J. Antibiot., 47, 301 (1994), Weidle, U., et al.: Anticancer Res., 20, 1471 (2000), Kitazono, M., et al.: Cancer Res., 61, 6328 (2001), Sandor, V., et al.: Clin. Cancer Res., 8, 718 (2002),<br></p>Formula:C24D8H28N4O6S2Color and Shape:NeatMolecular weight:548.745






